Aptevo announces platform presentation at SITC 2026
- Presenting at SITC 2026 Annual Meeting, Nov 4-8, 2026
- Showcasing multispecific platform targeting tumor microenvironment
- CD40-directed molecules aim to enhance immune response
Every EDGAR filing for Aptevo Therapeutics Inc. (APVO), newest first, with AI summaries and stories.
Next: earnings expected ~Nov 10 · 10-Q expected ~Nov 10 (deadline Nov 16)
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
Ownership stake disclosure by CVI Investments, Inc. (amended)
CVI Investments, Inc., filed by
Zsolt Harsanyi, insider filing for APVO
Zsolt Harsanyi, reporting
Ownership stake disclosure by NIOWAVE, INC.
NIOWAVE, INC., filed by
NIOWAVE, INC., new insider at APVO
NIOWAVE, INC., reporting
Mary Jo Janatpour, new insider at APVO
Mary Jo Janatpour, reporting
Ownership stake disclosure by Point72 Asset Management, L.P. (amended)
Point72 Asset Management, L.P., filed by
Ownership stake disclosure by CVI Investments, Inc. (amended)
CVI Investments, Inc., filed by